Global Genetically Modified Drug Market Research Report 2026(Status and Outlook)
Drugs made by genetically modified means are also called "biological drugs"According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The global Genetically Modified Drug market size was estimated at USD 2587.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genetically Modified Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genetically Modified Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genetically Modified Drug market.
Global Genetically Modified Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Market Segmentation (by Type)
Transgenic Animal
Transgenic Plant
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genetically Modified Drug Market
Overview of the regional outlook of the Genetically Modified Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetically Modified Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genetically Modified Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Genetically Modified Drug market size was estimated at USD 2587.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genetically Modified Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genetically Modified Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genetically Modified Drug market.
Global Genetically Modified Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Market Segmentation (by Type)
Transgenic Animal
Transgenic Plant
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genetically Modified Drug Market
Overview of the regional outlook of the Genetically Modified Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetically Modified Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genetically Modified Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Genetically Modified Drug
1.2 Key Market Segments
1.2.1 Genetically Modified Drug Segment by Type
1.2.2 Genetically Modified Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENETICALLY MODIFIED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genetically Modified Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Genetically Modified Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENETICALLY MODIFIED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genetically Modified Drug Product Life Cycle
3.3 Global Genetically Modified Drug Sales by Manufacturers (2020-2025)
3.4 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Genetically Modified Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Genetically Modified Drug Market Competitive Situation and Trends
3.8.1 Genetically Modified Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Genetically Modified Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENETICALLY MODIFIED DRUG INDUSTRY CHAIN ANALYSIS
4.1 Genetically Modified Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENETICALLY MODIFIED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genetically Modified Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Genetically Modified Drug Market
5.7 ESG Ratings of Leading Companies
6 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetically Modified Drug Sales Market Share by Type (2020-2025)
6.3 Global Genetically Modified Drug Market Size by Type (2020-2025)
6.4 Global Genetically Modified Drug Price by Type (2020-2025)
7 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetically Modified Drug Market Sales by Application (2020-2025)
7.3 Global Genetically Modified Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Genetically Modified Drug Sales Growth Rate by Application (2020-2025)
8 GENETICALLY MODIFIED DRUG MARKET SALES BY REGION
8.1 Global Genetically Modified Drug Sales by Region
8.1.1 Global Genetically Modified Drug Sales by Region
8.1.2 Global Genetically Modified Drug Sales Market Share by Region
8.2 Global Genetically Modified Drug Market Size by Region
8.2.1 Global Genetically Modified Drug Market Size by Region
8.2.2 Global Genetically Modified Drug Market Size by Region
8.3 North America
8.3.1 North America Genetically Modified Drug Sales by Country
8.3.2 North America Genetically Modified Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Genetically Modified Drug Sales by Country
8.4.2 Europe Genetically Modified Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Genetically Modified Drug Sales by Region
8.5.2 Asia Pacific Genetically Modified Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Genetically Modified Drug Sales by Country
8.6.2 South America Genetically Modified Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Genetically Modified Drug Sales by Region
8.7.2 Middle East and Africa Genetically Modified Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENETICALLY MODIFIED DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Genetically Modified Drug by Region(2020-2025)
9.2 Global Genetically Modified Drug Revenue Market Share by Region (2020-2025)
9.3 Global Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Genetically Modified Drug Production
9.4.1 North America Genetically Modified Drug Production Growth Rate (2020-2025)
9.4.2 North America Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Genetically Modified Drug Production
9.5.1 Europe Genetically Modified Drug Production Growth Rate (2020-2025)
9.5.2 Europe Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Genetically Modified Drug Production (2020-2025)
9.6.1 Japan Genetically Modified Drug Production Growth Rate (2020-2025)
9.6.2 Japan Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Genetically Modified Drug Production (2020-2025)
9.7.1 China Genetically Modified Drug Production Growth Rate (2020-2025)
9.7.2 China Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 LFB Biotechnologies SA
10.1.1 LFB Biotechnologies SA Basic Information
10.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Overview
10.1.3 LFB Biotechnologies SA Genetically Modified Drug Product Market Performance
10.1.4 LFB Biotechnologies SA Business Overview
10.1.5 LFB Biotechnologies SA SWOT Analysis
10.1.6 LFB Biotechnologies SA Recent Developments
10.2 Pharming Group NV
10.2.1 Pharming Group NV Basic Information
10.2.2 Pharming Group NV Genetically Modified Drug Product Overview
10.2.3 Pharming Group NV Genetically Modified Drug Product Market Performance
10.2.4 Pharming Group NV Business Overview
10.2.5 Pharming Group NV SWOT Analysis
10.2.6 Pharming Group NV Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer Genetically Modified Drug Product Overview
10.3.3 Pfizer Genetically Modified Drug Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Genetically Modified Drug Product Overview
10.4.3 Roche Genetically Modified Drug Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Basic Information
10.5.2 Abbott Laboratories Genetically Modified Drug Product Overview
10.5.3 Abbott Laboratories Genetically Modified Drug Product Market Performance
10.5.4 Abbott Laboratories Business Overview
10.5.5 Abbott Laboratories Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Genetically Modified Drug Product Overview
10.6.3 Johnson and Johnson Genetically Modified Drug Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 Merck and Co.
10.7.1 Merck and Co. Basic Information
10.7.2 Merck and Co. Genetically Modified Drug Product Overview
10.7.3 Merck and Co. Genetically Modified Drug Product Market Performance
10.7.4 Merck and Co. Business Overview
10.7.5 Merck and Co. Recent Developments
10.8 Amgen
10.8.1 Amgen Basic Information
10.8.2 Amgen Genetically Modified Drug Product Overview
10.8.3 Amgen Genetically Modified Drug Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 F. Hoffmann-La Roche
10.9.1 F. Hoffmann-La Roche Basic Information
10.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Overview
10.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product Market Performance
10.9.4 F. Hoffmann-La Roche Business Overview
10.9.5 F. Hoffmann-La Roche Recent Developments
10.10 Sanofi
10.10.1 Sanofi Basic Information
10.10.2 Sanofi Genetically Modified Drug Product Overview
10.10.3 Sanofi Genetically Modified Drug Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Novartis
10.11.1 Novartis Basic Information
10.11.2 Novartis Genetically Modified Drug Product Overview
10.11.3 Novartis Genetically Modified Drug Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly Basic Information
10.12.2 Eli Lilly Genetically Modified Drug Product Overview
10.12.3 Eli Lilly Genetically Modified Drug Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Takeda
10.13.1 Takeda Basic Information
10.13.2 Takeda Genetically Modified Drug Product Overview
10.13.3 Takeda Genetically Modified Drug Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 Baxter
10.14.1 Baxter Basic Information
10.14.2 Baxter Genetically Modified Drug Product Overview
10.14.3 Baxter Genetically Modified Drug Product Market Performance
10.14.4 Baxter Business Overview
10.14.5 Baxter Recent Developments
10.15 GlaxoSmithKline
10.15.1 GlaxoSmithKline Basic Information
10.15.2 GlaxoSmithKline Genetically Modified Drug Product Overview
10.15.3 GlaxoSmithKline Genetically Modified Drug Product Market Performance
10.15.4 GlaxoSmithKline Business Overview
10.15.5 GlaxoSmithKline Recent Developments
11 GENETICALLY MODIFIED DRUG MARKET FORECAST BY REGION
11.1 Global Genetically Modified Drug Market Size Forecast
11.2 Global Genetically Modified Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genetically Modified Drug Market Size Forecast by Country
11.2.3 Asia Pacific Genetically Modified Drug Market Size Forecast by Region
11.2.4 South America Genetically Modified Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Genetically Modified Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Genetically Modified Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Genetically Modified Drug by Type (2026-2035)
12.1.2 Global Genetically Modified Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Genetically Modified Drug by Type (2026-2035)
12.2 Global Genetically Modified Drug Market Forecast by Application (2026-2035)
12.2.1 Global Genetically Modified Drug Sales (K MT) Forecast by Application
12.2.2 Global Genetically Modified Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Genetically Modified Drug
1.2 Key Market Segments
1.2.1 Genetically Modified Drug Segment by Type
1.2.2 Genetically Modified Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENETICALLY MODIFIED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genetically Modified Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Genetically Modified Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENETICALLY MODIFIED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genetically Modified Drug Product Life Cycle
3.3 Global Genetically Modified Drug Sales by Manufacturers (2020-2025)
3.4 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Genetically Modified Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Genetically Modified Drug Market Competitive Situation and Trends
3.8.1 Genetically Modified Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Genetically Modified Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENETICALLY MODIFIED DRUG INDUSTRY CHAIN ANALYSIS
4.1 Genetically Modified Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENETICALLY MODIFIED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genetically Modified Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Genetically Modified Drug Market
5.7 ESG Ratings of Leading Companies
6 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetically Modified Drug Sales Market Share by Type (2020-2025)
6.3 Global Genetically Modified Drug Market Size by Type (2020-2025)
6.4 Global Genetically Modified Drug Price by Type (2020-2025)
7 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetically Modified Drug Market Sales by Application (2020-2025)
7.3 Global Genetically Modified Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Genetically Modified Drug Sales Growth Rate by Application (2020-2025)
8 GENETICALLY MODIFIED DRUG MARKET SALES BY REGION
8.1 Global Genetically Modified Drug Sales by Region
8.1.1 Global Genetically Modified Drug Sales by Region
8.1.2 Global Genetically Modified Drug Sales Market Share by Region
8.2 Global Genetically Modified Drug Market Size by Region
8.2.1 Global Genetically Modified Drug Market Size by Region
8.2.2 Global Genetically Modified Drug Market Size by Region
8.3 North America
8.3.1 North America Genetically Modified Drug Sales by Country
8.3.2 North America Genetically Modified Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Genetically Modified Drug Sales by Country
8.4.2 Europe Genetically Modified Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Genetically Modified Drug Sales by Region
8.5.2 Asia Pacific Genetically Modified Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Genetically Modified Drug Sales by Country
8.6.2 South America Genetically Modified Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Genetically Modified Drug Sales by Region
8.7.2 Middle East and Africa Genetically Modified Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENETICALLY MODIFIED DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Genetically Modified Drug by Region(2020-2025)
9.2 Global Genetically Modified Drug Revenue Market Share by Region (2020-2025)
9.3 Global Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Genetically Modified Drug Production
9.4.1 North America Genetically Modified Drug Production Growth Rate (2020-2025)
9.4.2 North America Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Genetically Modified Drug Production
9.5.1 Europe Genetically Modified Drug Production Growth Rate (2020-2025)
9.5.2 Europe Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Genetically Modified Drug Production (2020-2025)
9.6.1 Japan Genetically Modified Drug Production Growth Rate (2020-2025)
9.6.2 Japan Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Genetically Modified Drug Production (2020-2025)
9.7.1 China Genetically Modified Drug Production Growth Rate (2020-2025)
9.7.2 China Genetically Modified Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 LFB Biotechnologies SA
10.1.1 LFB Biotechnologies SA Basic Information
10.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Overview
10.1.3 LFB Biotechnologies SA Genetically Modified Drug Product Market Performance
10.1.4 LFB Biotechnologies SA Business Overview
10.1.5 LFB Biotechnologies SA SWOT Analysis
10.1.6 LFB Biotechnologies SA Recent Developments
10.2 Pharming Group NV
10.2.1 Pharming Group NV Basic Information
10.2.2 Pharming Group NV Genetically Modified Drug Product Overview
10.2.3 Pharming Group NV Genetically Modified Drug Product Market Performance
10.2.4 Pharming Group NV Business Overview
10.2.5 Pharming Group NV SWOT Analysis
10.2.6 Pharming Group NV Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer Genetically Modified Drug Product Overview
10.3.3 Pfizer Genetically Modified Drug Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Genetically Modified Drug Product Overview
10.4.3 Roche Genetically Modified Drug Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Basic Information
10.5.2 Abbott Laboratories Genetically Modified Drug Product Overview
10.5.3 Abbott Laboratories Genetically Modified Drug Product Market Performance
10.5.4 Abbott Laboratories Business Overview
10.5.5 Abbott Laboratories Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Genetically Modified Drug Product Overview
10.6.3 Johnson and Johnson Genetically Modified Drug Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 Merck and Co.
10.7.1 Merck and Co. Basic Information
10.7.2 Merck and Co. Genetically Modified Drug Product Overview
10.7.3 Merck and Co. Genetically Modified Drug Product Market Performance
10.7.4 Merck and Co. Business Overview
10.7.5 Merck and Co. Recent Developments
10.8 Amgen
10.8.1 Amgen Basic Information
10.8.2 Amgen Genetically Modified Drug Product Overview
10.8.3 Amgen Genetically Modified Drug Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 F. Hoffmann-La Roche
10.9.1 F. Hoffmann-La Roche Basic Information
10.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Overview
10.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product Market Performance
10.9.4 F. Hoffmann-La Roche Business Overview
10.9.5 F. Hoffmann-La Roche Recent Developments
10.10 Sanofi
10.10.1 Sanofi Basic Information
10.10.2 Sanofi Genetically Modified Drug Product Overview
10.10.3 Sanofi Genetically Modified Drug Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Novartis
10.11.1 Novartis Basic Information
10.11.2 Novartis Genetically Modified Drug Product Overview
10.11.3 Novartis Genetically Modified Drug Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly Basic Information
10.12.2 Eli Lilly Genetically Modified Drug Product Overview
10.12.3 Eli Lilly Genetically Modified Drug Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Takeda
10.13.1 Takeda Basic Information
10.13.2 Takeda Genetically Modified Drug Product Overview
10.13.3 Takeda Genetically Modified Drug Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 Baxter
10.14.1 Baxter Basic Information
10.14.2 Baxter Genetically Modified Drug Product Overview
10.14.3 Baxter Genetically Modified Drug Product Market Performance
10.14.4 Baxter Business Overview
10.14.5 Baxter Recent Developments
10.15 GlaxoSmithKline
10.15.1 GlaxoSmithKline Basic Information
10.15.2 GlaxoSmithKline Genetically Modified Drug Product Overview
10.15.3 GlaxoSmithKline Genetically Modified Drug Product Market Performance
10.15.4 GlaxoSmithKline Business Overview
10.15.5 GlaxoSmithKline Recent Developments
11 GENETICALLY MODIFIED DRUG MARKET FORECAST BY REGION
11.1 Global Genetically Modified Drug Market Size Forecast
11.2 Global Genetically Modified Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genetically Modified Drug Market Size Forecast by Country
11.2.3 Asia Pacific Genetically Modified Drug Market Size Forecast by Region
11.2.4 South America Genetically Modified Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Genetically Modified Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Genetically Modified Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Genetically Modified Drug by Type (2026-2035)
12.1.2 Global Genetically Modified Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Genetically Modified Drug by Type (2026-2035)
12.2 Global Genetically Modified Drug Market Forecast by Application (2026-2035)
12.2.1 Global Genetically Modified Drug Sales (K MT) Forecast by Application
12.2.2 Global Genetically Modified Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Genetically Modified Drug Market Size by Type (M USD)
Table 4. Global Genetically Modified Drug Market Size by Application
Table 5. Genetically Modified Drug Market Size Comparison by Region (M USD)
Table 6. Global Genetically Modified Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Genetically Modified Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Genetically Modified Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Genetically Modified Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2025)
Table 11. Global Market Genetically Modified Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Genetically Modified Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Genetically Modified Drug Sales by Type (K MT)
Table 27. Global Genetically Modified Drug Market Size by Type (M USD)
Table 28. Global Genetically Modified Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Genetically Modified Drug Sales Market Share by Type (2020-2025)
Table 30. Global Genetically Modified Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Genetically Modified Drug Market Share by Type (2020-2025)
Table 32. Global Genetically Modified Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Genetically Modified Drug Sales (K MT) by Application
Table 34. Global Genetically Modified Drug Market Size by Application
Table 35. Global Genetically Modified Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Genetically Modified Drug Sales Market Share by Application (2020-2025)
Table 37. Global Genetically Modified Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Genetically Modified Drug Market Share by Application (2020-2025)
Table 39. Global Genetically Modified Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Genetically Modified Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Genetically Modified Drug Sales Market Share by Region (2020-2025)
Table 42. Global Genetically Modified Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Genetically Modified Drug Market Size by Region (2020-2025)
Table 44. North America Genetically Modified Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Genetically Modified Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Genetically Modified Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Genetically Modified Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Genetically Modified Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Genetically Modified Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Genetically Modified Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Genetically Modified Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Genetically Modified Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Genetically Modified Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Genetically Modified Drug Production (K MT) by Region(2020-2025)
Table 55. Global Genetically Modified Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Genetically Modified Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. LFB Biotechnologies SA Basic Information
Table 63. LFB Biotechnologies SA Genetically Modified Drug Product Overview
Table 64. LFB Biotechnologies SA Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. LFB Biotechnologies SA Business Overview
Table 66. LFB Biotechnologies SA SWOT Analysis
Table 67. LFB Biotechnologies SA Recent Developments
Table 68. Pharming Group NV Basic Information
Table 69. Pharming Group NV Genetically Modified Drug Product Overview
Table 70. Pharming Group NV Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pharming Group NV Business Overview
Table 72. Pharming Group NV SWOT Analysis
Table 73. Pharming Group NV Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Genetically Modified Drug Product Overview
Table 76. Pfizer Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Roche Basic Information
Table 81. Roche Genetically Modified Drug Product Overview
Table 82. Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Roche Business Overview
Table 84. Roche Recent Developments
Table 85. Abbott Laboratories Basic Information
Table 86. Abbott Laboratories Genetically Modified Drug Product Overview
Table 87. Abbott Laboratories Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Genetically Modified Drug Product Overview
Table 92. Johnson and Johnson Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. Merck and Co. Basic Information
Table 96. Merck and Co. Genetically Modified Drug Product Overview
Table 97. Merck and Co. Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck and Co. Business Overview
Table 99. Merck and Co. Recent Developments
Table 100. Amgen Basic Information
Table 101. Amgen Genetically Modified Drug Product Overview
Table 102. Amgen Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Amgen Business Overview
Table 104. Amgen Recent Developments
Table 105. F. Hoffmann-La Roche Basic Information
Table 106. F. Hoffmann-La Roche Genetically Modified Drug Product Overview
Table 107. F. Hoffmann-La Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. F. Hoffmann-La Roche Business Overview
Table 109. F. Hoffmann-La Roche Recent Developments
Table 110. Sanofi Basic Information
Table 111. Sanofi Genetically Modified Drug Product Overview
Table 112. Sanofi Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Sanofi Business Overview
Table 114. Sanofi Recent Developments
Table 115. Novartis Basic Information
Table 116. Novartis Genetically Modified Drug Product Overview
Table 117. Novartis Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Novartis Business Overview
Table 119. Novartis Recent Developments
Table 120. Eli Lilly Basic Information
Table 121. Eli Lilly Genetically Modified Drug Product Overview
Table 122. Eli Lilly Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Eli Lilly Business Overview
Table 124. Eli Lilly Recent Developments
Table 125. Takeda Basic Information
Table 126. Takeda Genetically Modified Drug Product Overview
Table 127. Takeda Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Takeda Business Overview
Table 129. Takeda Recent Developments
Table 130. Baxter Basic Information
Table 131. Baxter Genetically Modified Drug Product Overview
Table 132. Baxter Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Baxter Business Overview
Table 134. Baxter Recent Developments
Table 135. GlaxoSmithKline Basic Information
Table 136. GlaxoSmithKline Genetically Modified Drug Product Overview
Table 137. GlaxoSmithKline Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. GlaxoSmithKline Business Overview
Table 139. GlaxoSmithKline Recent Developments
Table 140. Global Genetically Modified Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Genetically Modified Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Genetically Modified Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Genetically Modified Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Genetically Modified Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Genetically Modified Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Genetically Modified Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Genetically Modified Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Genetically Modified Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Genetically Modified Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Genetically Modified Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Genetically Modified Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Genetically Modified Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Genetically Modified Drug Market Size by Type (M USD)
Table 4. Global Genetically Modified Drug Market Size by Application
Table 5. Genetically Modified Drug Market Size Comparison by Region (M USD)
Table 6. Global Genetically Modified Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Genetically Modified Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Genetically Modified Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Genetically Modified Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2025)
Table 11. Global Market Genetically Modified Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Genetically Modified Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Genetically Modified Drug Sales by Type (K MT)
Table 27. Global Genetically Modified Drug Market Size by Type (M USD)
Table 28. Global Genetically Modified Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Genetically Modified Drug Sales Market Share by Type (2020-2025)
Table 30. Global Genetically Modified Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Genetically Modified Drug Market Share by Type (2020-2025)
Table 32. Global Genetically Modified Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Genetically Modified Drug Sales (K MT) by Application
Table 34. Global Genetically Modified Drug Market Size by Application
Table 35. Global Genetically Modified Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Genetically Modified Drug Sales Market Share by Application (2020-2025)
Table 37. Global Genetically Modified Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Genetically Modified Drug Market Share by Application (2020-2025)
Table 39. Global Genetically Modified Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Genetically Modified Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Genetically Modified Drug Sales Market Share by Region (2020-2025)
Table 42. Global Genetically Modified Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Genetically Modified Drug Market Size by Region (2020-2025)
Table 44. North America Genetically Modified Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Genetically Modified Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Genetically Modified Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Genetically Modified Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Genetically Modified Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Genetically Modified Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Genetically Modified Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Genetically Modified Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Genetically Modified Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Genetically Modified Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Genetically Modified Drug Production (K MT) by Region(2020-2025)
Table 55. Global Genetically Modified Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Genetically Modified Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. LFB Biotechnologies SA Basic Information
Table 63. LFB Biotechnologies SA Genetically Modified Drug Product Overview
Table 64. LFB Biotechnologies SA Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. LFB Biotechnologies SA Business Overview
Table 66. LFB Biotechnologies SA SWOT Analysis
Table 67. LFB Biotechnologies SA Recent Developments
Table 68. Pharming Group NV Basic Information
Table 69. Pharming Group NV Genetically Modified Drug Product Overview
Table 70. Pharming Group NV Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pharming Group NV Business Overview
Table 72. Pharming Group NV SWOT Analysis
Table 73. Pharming Group NV Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Genetically Modified Drug Product Overview
Table 76. Pfizer Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Roche Basic Information
Table 81. Roche Genetically Modified Drug Product Overview
Table 82. Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Roche Business Overview
Table 84. Roche Recent Developments
Table 85. Abbott Laboratories Basic Information
Table 86. Abbott Laboratories Genetically Modified Drug Product Overview
Table 87. Abbott Laboratories Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Genetically Modified Drug Product Overview
Table 92. Johnson and Johnson Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. Merck and Co. Basic Information
Table 96. Merck and Co. Genetically Modified Drug Product Overview
Table 97. Merck and Co. Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck and Co. Business Overview
Table 99. Merck and Co. Recent Developments
Table 100. Amgen Basic Information
Table 101. Amgen Genetically Modified Drug Product Overview
Table 102. Amgen Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Amgen Business Overview
Table 104. Amgen Recent Developments
Table 105. F. Hoffmann-La Roche Basic Information
Table 106. F. Hoffmann-La Roche Genetically Modified Drug Product Overview
Table 107. F. Hoffmann-La Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. F. Hoffmann-La Roche Business Overview
Table 109. F. Hoffmann-La Roche Recent Developments
Table 110. Sanofi Basic Information
Table 111. Sanofi Genetically Modified Drug Product Overview
Table 112. Sanofi Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Sanofi Business Overview
Table 114. Sanofi Recent Developments
Table 115. Novartis Basic Information
Table 116. Novartis Genetically Modified Drug Product Overview
Table 117. Novartis Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Novartis Business Overview
Table 119. Novartis Recent Developments
Table 120. Eli Lilly Basic Information
Table 121. Eli Lilly Genetically Modified Drug Product Overview
Table 122. Eli Lilly Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Eli Lilly Business Overview
Table 124. Eli Lilly Recent Developments
Table 125. Takeda Basic Information
Table 126. Takeda Genetically Modified Drug Product Overview
Table 127. Takeda Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Takeda Business Overview
Table 129. Takeda Recent Developments
Table 130. Baxter Basic Information
Table 131. Baxter Genetically Modified Drug Product Overview
Table 132. Baxter Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Baxter Business Overview
Table 134. Baxter Recent Developments
Table 135. GlaxoSmithKline Basic Information
Table 136. GlaxoSmithKline Genetically Modified Drug Product Overview
Table 137. GlaxoSmithKline Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. GlaxoSmithKline Business Overview
Table 139. GlaxoSmithKline Recent Developments
Table 140. Global Genetically Modified Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Genetically Modified Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Genetically Modified Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Genetically Modified Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Genetically Modified Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Genetically Modified Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Genetically Modified Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Genetically Modified Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Genetically Modified Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Genetically Modified Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Genetically Modified Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Genetically Modified Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Genetically Modified Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Genetically Modified Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Genetically Modified Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genetically Modified Drug Market Size (M USD), 2025-2035
Figure 5. Global Genetically Modified Drug Market Size (M USD) (2020-2035)
Figure 6. Global Genetically Modified Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genetically Modified Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Genetically Modified Drug Product Life Cycle
Figure 13. Genetically Modified Drug Sales Share by Manufacturers in 2025
Figure 14. Global Genetically Modified Drug Revenue Share by Manufacturers in 2025
Figure 15. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Genetically Modified Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Genetically Modified Drug Revenue in 2025
Figure 18. Industry Chain Map of Genetically Modified Drug
Figure 19. Global Genetically Modified Drug Market PEST Analysis
Figure 20. Global Genetically Modified Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Genetically Modified Drug Market Share by Type
Figure 27. Sales Market Share of Genetically Modified Drug by Type (2020-2025)
Figure 28. Sales Market Share of Genetically Modified Drug by Type in 2025
Figure 29. Market Share of Genetically Modified Drug by Type (2020-2025)
Figure 30. Market Share of Genetically Modified Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Genetically Modified Drug Market Share by Application
Figure 33. Global Genetically Modified Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Genetically Modified Drug Sales Market Share by Application in 2025
Figure 35. Global Genetically Modified Drug Market Share by Application (2020-2025)
Figure 36. Global Genetically Modified Drug Market Share by Application in 2025
Figure 37. Global Genetically Modified Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Genetically Modified Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Genetically Modified Drug Market Size by Region (2020-2025)
Figure 40. North America Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Genetically Modified Drug Sales Market Share by Country in 2024
Figure 43. North America Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Genetically Modified Drug Market Size by Country in 2024
Figure 45. U.S. Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Genetically Modified Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Genetically Modified Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Genetically Modified Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Genetically Modified Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Genetically Modified Drug Sales Market Share by Country in 2024
Figure 53. Europe Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Genetically Modified Drug Market Size by Country in 2024
Figure 55. Germany Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Genetically Modified Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Genetically Modified Drug Market Size by Region in 2024
Figure 68. China Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 79. South America Genetically Modified Drug Sales Market Share by Country in 2024
Figure 80. South America Genetically Modified Drug Market Size and Growth Rate (M USD)
Figure 81. South America Genetically Modified Drug Market Size by Country in 2024
Figure 82. Brazil Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Genetically Modified Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Genetically Modified Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Genetically Modified Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Genetically Modified Drug Production Market Share by Region (2020-2025)
Figure 103. North America Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Genetically Modified Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Genetically Modified Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Genetically Modified Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Genetically Modified Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Genetically Modified Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Genetically Modified Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Genetically Modified Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genetically Modified Drug Market Size (M USD), 2025-2035
Figure 5. Global Genetically Modified Drug Market Size (M USD) (2020-2035)
Figure 6. Global Genetically Modified Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genetically Modified Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Genetically Modified Drug Product Life Cycle
Figure 13. Genetically Modified Drug Sales Share by Manufacturers in 2025
Figure 14. Global Genetically Modified Drug Revenue Share by Manufacturers in 2025
Figure 15. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Genetically Modified Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Genetically Modified Drug Revenue in 2025
Figure 18. Industry Chain Map of Genetically Modified Drug
Figure 19. Global Genetically Modified Drug Market PEST Analysis
Figure 20. Global Genetically Modified Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Genetically Modified Drug Market Share by Type
Figure 27. Sales Market Share of Genetically Modified Drug by Type (2020-2025)
Figure 28. Sales Market Share of Genetically Modified Drug by Type in 2025
Figure 29. Market Share of Genetically Modified Drug by Type (2020-2025)
Figure 30. Market Share of Genetically Modified Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Genetically Modified Drug Market Share by Application
Figure 33. Global Genetically Modified Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Genetically Modified Drug Sales Market Share by Application in 2025
Figure 35. Global Genetically Modified Drug Market Share by Application (2020-2025)
Figure 36. Global Genetically Modified Drug Market Share by Application in 2025
Figure 37. Global Genetically Modified Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Genetically Modified Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Genetically Modified Drug Market Size by Region (2020-2025)
Figure 40. North America Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Genetically Modified Drug Sales Market Share by Country in 2024
Figure 43. North America Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Genetically Modified Drug Market Size by Country in 2024
Figure 45. U.S. Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Genetically Modified Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Genetically Modified Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Genetically Modified Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Genetically Modified Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Genetically Modified Drug Sales Market Share by Country in 2024
Figure 53. Europe Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Genetically Modified Drug Market Size by Country in 2024
Figure 55. Germany Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Genetically Modified Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Genetically Modified Drug Market Size by Region in 2024
Figure 68. China Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 79. South America Genetically Modified Drug Sales Market Share by Country in 2024
Figure 80. South America Genetically Modified Drug Market Size and Growth Rate (M USD)
Figure 81. South America Genetically Modified Drug Market Size by Country in 2024
Figure 82. Brazil Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Genetically Modified Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Genetically Modified Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Genetically Modified Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Genetically Modified Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Genetically Modified Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Genetically Modified Drug Production Market Share by Region (2020-2025)
Figure 103. North America Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Genetically Modified Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Genetically Modified Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Genetically Modified Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Genetically Modified Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Genetically Modified Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Genetically Modified Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Genetically Modified Drug Market Share Forecast by Application (2026-2035)
